Team:Missouri Miners

From 2011.igem.org

(Difference between revisions)
Line 1: Line 1:
-
{| style="color:#006400; background-color:#eac117;" cellpadding="3" cellspacing="1" border="0px solid" bordercolor="#006400" width="100%" align="center"
+
{| style="color:#006400; background-color:c0c0c0;" cellpadding="3" cellspacing="1" border="0px solid" bordercolor="#006400" width="100%" align="center"
!align="center"|[[Team:Missouri_Miners|Home]]
!align="center"|[[Team:Missouri_Miners|Home]]
!align="center"|[[Team:Missouri_Miners/Team|Team]]
!align="center"|[[Team:Missouri_Miners/Team|Team]]
Line 11: Line 11:
|}
|}
-
<div id="box" style="width: 850px; margin-left: 40px; padding: 5px; border: 15px solid #006400; background-color: #c0c0c0;">
+
<div id="box" style="width: 925px; margin-left: 0px; padding: 5px; border: 15px solid #006400; background-color: #000000;">
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #006400; padding: 5px;">
+
<div id="template" style="text-align: center; font-weight: regular; font-size: large; color: #c0c0c0; padding: 5px;">
-
Project Summary
+
Project Abstract
</div>
</div>
-
<div id="instructions" style="text-align: center; font-weight: bold; font-size: small; color: black; padding: 5px;">
+
<div id="instructions" style="text-align: center; font-weight: regular; font-size: large; color: silver; padding: 5px;"><p><font face="Berlin Sans FB"><font size="7" face="Berlin Sans FB" color="green">I</font>n the bodies of people with diabetes, the ability to recognize and respond to glucose concentrations in the blood has been compromised. As a result, glucose accumulates to dangerous levels. High blood glucose concentrations can cause irreversible damage to critical organs, impairing their functionality. With parts from the iGEM registry, our team created a glucose-controlled promoter linked to a yellow fluorescence production gene in E. coli. The concentrations of glucose to which the promoter responds can be determined. Once the concentration is known, the promoter can be mutated so that it will be activated by varying concentrations of glucose and be used as a glucose sensor for people with diabetes. In the future, an insulin gene could be added to this system for use in insulin pumps, where specific glucose levels trigger insulin production in E. coli.
-
We are attempting to integrate a glucose controlled promoter gene (Omp-R) linked to a green flousecence producing gene (eYFP) in order to measure the concentration of glucose recquired to activate the promoter gene. Once this concentration is known, we will be attempting to mutate the Omp-R promoter gene so that it will be activated by glucose concentrations closer to those of the average human.
+
 
-
</div>
+
 
-
</div>
+
 
-
<br>
+
-
<div id="box" style="width: 850px; margin-left: 40px; padding: 5px; border: 15px solid #006400; background-color: #c0c0c0;">
 
-
<div style="color: black; font-weight: bold; font-size: large" align="center">
 
The Team of 2011
The Team of 2011
-
</div>
+
 
-
<div align="center">
+
[[File:Blank.jpg]]
[[File:Blank.jpg]]
-
</div>
+
<br>
-
</div>
+

Revision as of 01:51, 1 September 2011

Home Team Official Team Profile Project Parts Submitted to the Registry Modeling Notebook Safety Attributions

Project Abstract

In the bodies of people with diabetes, the ability to recognize and respond to glucose concentrations in the blood has been compromised. As a result, glucose accumulates to dangerous levels. High blood glucose concentrations can cause irreversible damage to critical organs, impairing their functionality. With parts from the iGEM registry, our team created a glucose-controlled promoter linked to a yellow fluorescence production gene in E. coli. The concentrations of glucose to which the promoter responds can be determined. Once the concentration is known, the promoter can be mutated so that it will be activated by varying concentrations of glucose and be used as a glucose sensor for people with diabetes. In the future, an insulin gene could be added to this system for use in insulin pumps, where specific glucose levels trigger insulin production in E. coli.



The Team of 2011

Blank.jpg